POINT BIOPHARMA GLOBAL INC. Depreciation
POINT BIOPHARMA GLOBAL INC. reported Depreciation of $2.19 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. depreciation for the quarter ending 2023-09-30 was $863.92K, a 117.66% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. depreciation for the quarter ending 2023-06-30 was $784.70K, a 118.07% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. depreciation for the quarter ending 2023-03-31 was $537.63K, a 139.76% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. depreciation for the quarter ending 2022-12-31 was $414.03K.
- POINT BIOPHARMA GLOBAL INC. depreciation for fiscal 2022 was $1.40M.
- POINT BIOPHARMA GLOBAL INC. depreciation for fiscal 2021 was $0.00.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2023-09-30 | $863.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.65M derived: sum of 2 quarters · filed 2023-11-13 | $2.19M 10-Q · filed 2023-11-13 | $2.60M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $784.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.32M 10-Q · filed 2023-08-14 | $1.74M derived: sum of 3 quarters · filed 2023-08-14 | $2.13M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $537.63K 10-Q · filed 2023-05-15 | $951.66K derived: sum of 2 quarters · filed 2023-05-15 | $1.35M derived: sum of 3 quarters · filed 2023-11-13 | $1.71M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $414.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $810.95K derived: sum of 2 quarters · filed 2023-11-13 | $1.17M derived: sum of 3 quarters · filed 2023-11-13 | $1.40M 10-K · filed 2023-03-27 |
| 2022-09-30 | $396.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $756.76K derived: sum of 2 quarters · filed 2023-11-13 | $981.00K 10-Q · filed 2023-11-13 | $981.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $359.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $584.08K 10-Q · filed 2023-08-14 | $584.08K derived: sum of 3 quarters · filed 2023-08-14 | $584.08K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $224.23K 10-Q · filed 2023-05-15 | $224.23K derived: sum of 2 quarters · filed 2023-05-15 | $224.23K derived: sum of 3 quarters · filed 2023-05-15 | $224.23K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $0.00 derived: sum of 2 quarters · filed 2023-03-27 | $0.00 derived: sum of 3 quarters · filed 2023-03-27 | $0.00 10-K · filed 2023-03-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 |